Health Care

Active Stocks To Observe: Cerulean Pharma Inc. (NASDAQ:CERU), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

0 17

Cerulean Pharma Inc. (NASDAQ:CERU) went higher by +29.82% to close at $ 2.96. The company exchanged total volume of 3.4 million shares throughout course of last trade however it holds an average trading capacity of 177.89 thousand shares. Shares of company began trading at $2.58 climbed to high of $3.09 touched the low of $2.52.

The company is trading above its 50-day moving averages of 2.24 and up from 200-day moving averages of 2.49. The firm has price to book ratio of 1.73

Cerulean Pharma Inc.’s (CERU) has price-to-cash ratio of 1.23 A look on the firm performance, its monthly performance is 40.95% and a quarterly performance of -18.01%. The stock price is moving up from its 20 days moving average with 37.72% and isolated positively from 50 days moving average with 31.46%.

Cerulean Pharma Inc. (CERU), a clinical-stage firmdeveloping nanoparticle-drug conjugates (NDCs), recently reported that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for Cerulean’s lead nanoparticle-drug conjugate, CRLX101, in combination with paclitaxel, for the treatment of platinum-resistant ovarian carcinoma, fallopian tube or primary peritoneal cancer.

 

“We appreciate the FDA’s acknowledgement of CRLX101’s potential in an area of important unmet medical need,” stated Christopher D. T. Guiffre, President and Chief Executive Officer of Cerulean. “We are encouraged by the profound treatment effect observed early in the ongoing clinical trial with the GOG Foundation, Inc. (GOG), and we look forward to working closely with the FDA as we endeavor to bring a new treatment option to women living with platinum-resistant ovarian cancer.”

Brokerage Recommendations:

According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. 1 Month Ago,  shares have been suggested as “BUY” from “0” brokerage firms and recommended as “Strong Buy” by “0” brokerage firms. 0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “1” brokerage firms. “0” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 0 based on consensus of the brokerage firms issuing ratings.

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) dropped -1.60% and closed the trade at $ 13.54. The company recorded a trading capacity of 1.05 million shares below its three months average daily volume of 1.48 million shares. During the last trade, shares reached to high price of $13.93 and touched the low price of $13.53. The stock’s 50-day moving average is noted at $12.93 and its 200-day moving average is stands at $10.99.

Additionally, the company has EPS of -0.86. The company has market capitalization of $1.96B.

The average true range of Ironwood Pharmaceuticals, Inc.’s (IRWD) is recorded at 0.50 and the relative strength index of the stock stands 60.20. The stock price is going above to its 52 week low with 84.22% and lagging behind from its 52 week high with -2.87%. Analyst recommendation for this stock stands at 2.50. A look on the firm performance, its monthly performance is 7.89% and a quarterly performance of 22.76%. The stock price is trading upbeat from its 200 days moving average with 21.43% and up from 50 days moving average with 9.70%.

Brokerage Recommendations:

According to ZACKS data, different Brokerage Firms rated the stock about their BUY, SELL or HOLD recommendations. 1 Month Ago,  shares have been suggested as “BUY” from “4” brokerage firms and recommended as “Strong Buy” by “0” brokerage firms. 0” brokerage firms have issued “Sell” rating for the company and “Strong Sell” rating was issued by “2” brokerage firms. “0” brokerage firms have rated the company as a “Hold”. The Corporation has average brokerage recommendation (ABR) of 0 based on consensus of the brokerage firms issuing ratings.

 

 

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

Advirtisement

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter